Pathology Associates Of Lexington, P.A.
Pathology Associates Of Lexington, P.A.
Pathology Associates Of Lexington, P.A.
 Home | Pathology Group MembersOur Hospital  Search This Website:
        Bronchoalveolar Lavage
      

BAL was introduced for therapy in 1922 & diagnostic use in 1974. BAL specimens may be obtained and sent to the lab for cytology, cell count with differential, cytopathology examination, and microbiology cultures. BAL for diagnosis of a focal process will come from that segment; assessment of diffuse lung disease usually comes from the RML or the left lung lingula, each accessible with patient supine; usually one or a series of 204-60 ml. instillations with fluid recovery & subsequent pooling3. These anterior sites allow "down-hill" return of fluid and a better yield. At least one authority3 writes that BAL can distinguish between the 3 entities (EAA, IPF, & sarcoidosis) said to cause 90% of cases of interstitial lung disease (ILD). Here are some notes that have come to our attention:

  • gross exam of fluid: milky fluid may reflect alveolar proteinosis1; others describe it as opaque brownish or sandy colored fluid which sediments out into layers if left to sit8.
  • total cell count: the normal adult non-smoker cell count is 4-23 cells per microliter1; smokers have higher counts1; or average a slightly lower count3.
  • cell sample differential percentages implications:
    • polys: are 0.1-4.4% of recovered cells1 (<3%8)& increased in smokers1; up to 5 fold increase & up to 5% of cells in smokers5. In scleroderma "activity" workups, one is more likely to consider therapy when greater than 3 polys per microliter7.
      • ***neutrophilia increases the likelihood of an underlying fibrosing process (IPF, fibrosing alveolitis of rheumatoid disease, asbestosis, or fibrotic sarcoid)6.
      • some hypersensitivity pneumonitis.
      • mild increase in EAA3.
      • some IPF have an increase3,5; 70-90% are 5% or more6.
      • mild increase in asbestosis.
      • increased in idiopathic fibrosis and collagen vascular diseases.
    • lymphocytes: are 10% (<15%8)of recovered cells2& mildly increased in smokers1. CD4/CD8 ratios might help in some DDXs (see8).
      • ***a BAL lymphocytosis is more suggestive of nonspecific interstitial pneumonia (NSIP), granulomatous disease, or a drug-induced lung disease6.
      •  lymphocytosis of T helper cells1 more likely reflects sarcoid; the helper:suppressor ratio (CD4/CD8) is frequently high3.
      • easily found (more than rare) lymphocytic rosettes around alveolar macrophages tend to reflect sarcoidosis2.
      • a lone lymphocytosis suggests sarcoidosis, granulomatous infection, hypersensitivity pneumonitis, BOOP, nonspecific interstitial pneumonia (NSIP), or LIP6.
      • mild increase in asbestosis.
      • some IPFs have an increase3; 10-20% have co-increase with other cells6. But IPF seldom has just a lone increase in lymphs and such indicates another disease6.
      • increased in silicosis.
      • present in berylliosis.
      • hypersensitivity pneumonitis (extrensic allergic alveolitis [EAA]) has increased suppressor T lymphocytes1 and a low CD4:CD8 ratio3.
    • eosinophiles: usually less than 1-2%8 of cells
      •  more likely reflects allergic or active asthmatic
      • stable asthmatics have up to 5%.
      • increased in idiopathic pulmonary fibrosis1 (IPF) and collagen vascular diseases; some IPFs have an increase3; 40-60% of IPFs have greater than 5%6.
      • greater than 40% eos seen with eosinophilic pneumonia or acute tropical pulmonary eosinophilia.
      • some hypersensitivity pneumonitis.
    • plasma cells:
      • presence highly suggestive of EAA (extrensic allergic alveolitis)3.
    • macrophage clues: usually 90% of rcovered cells in normal nonsmokers
      • macrophages tend to be (80%2) 84-99% of recovered cells1.
      • macs engulf RBCs within 48 hours of bleed8.
      • iron positivity reflects alveolar hemorrhage1.
      • easily found (more than rare) lymphocytic rosettes around alveolar macrophages tend to reflect sarcoidosis2.
      • foamy macs nonspecific but common if patient on amiodarone8.
      • a few Langerhans cells (dendritic macrophages) in smokers & some interstitial lung diseases & more numerous in eosinophilc granuloma1...and histiocytosis X...Langerhans cell histiocytoses (IHC for S100)8.
  • smears ID & cultures for microbiology:
    • DFA stain for whatever LML can DFA; Gram for bacteria; AFB stain; silver stain fungi & P. car. (PCP).
    • can send for PCR for various organisms such as M. tb.
    • can culture for bacteria, fungi, and AFB.
    • careful: healthy persons can shed cultureable CMV or HSV in absence of pneumonia, but finding of cytopathic change or inclusions is accepted as evidence of actual infection1.
    • upper lobe BAL specimens are the most likely to show organisms of P. carinii.
  • cancer cells: primary malignancies & even lymphangitic spread, can be seen1, 8.
  • polarized light exam: for talcosis, silicosis, & asbestosis bodies.
  • wet prep exam: could note ciliary action of repiratory epithelium as appearing normal or dysfunctional.
  • steroid responders: citing a 1981 study of "cryptogenic fibrosing alveolitis", the corticosteroid responders tended to have higher lymphocyte counts whereas the nonresponders had higher polys and eos5.

References:

  1. Goldstein RA, et. al., Official ATS Statement, Clinical Role of BAL in Adults With Pulmonary Disease, Am. Rev. Resp. Dis., 142:481-486, 1990.
  2. M Drent, MA van Nierop, FA Gerritsen, EF Wouters and PG Mulder
    Department of Pulmonology, University Hospital Maastricht, The Netherlands. A computer program using BALF-analysis results as a diagnostic tool in interstitial lung diseases, Am. J. Respir. Crit. Care Med., Vol 153, No. 2, 02 1996, 736-741.
  3. Drent, Marjolein, et. al., Interpretation of BALF Cytology, CD ROM information webfile (http://www.pul.unimaas.nl/theses/bal_cd.pdf.).
  4. Leslie KO & Wick MR, Practical Pulmonary Pathology: a Diagnostic Approach, 813 pages, 2005.
  5. Dail DH & Hammar SP, Pulmonary Pathology, 2nd Ed., 1640 pages, 1994.
  6. ATS International Concensus Statement, Idiopathic Pulmonary Fibrosis: Diagnosis and Treatment, Am. J. Respir. Crit. Care Med., Vol 161, No. 2, 02 2000, 646-664.
  7. per our pulmonologists.
  8. American Thoracic society website, BAL, on-line atlas of critical care procedures 12/08.

(posted 14 July 2005; latest addition 1 January 2008)

 
© Copyright 1999 - 2006, all rights reserved, Pathology Associates Of Lexington, P.A.